Dyslipidemia / Ragavendra R. Baliga, Christopher P. Cannon.

Format:

Book

Contributor:

Baliga, R. R.

Cannon, Christopher P.

Series:

Oxford American Cardiology Library

Language:

English

Subjects (All):

Lipids--Metabolism--Disorders--Treatment.

Lipids.

Atherosclerosis--Treatment.

Atherosclerosis.

Coronary heart disease.

Physical Description:

1 online resource (152 p.)

Edition:

1st ed.

Place of Publication:

Oxford ; New York : Oxford University Press, 2012.

Language Note:

English

Summary:

Dyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardial infarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control

Contents:

Cover; Contents; Contributors; 1 LDL Cholesterol; 2 HDL Cholesterol; 3 Non-HDL Cholesterol; 4 Use of High Sensitivity C-Reactive Protein for Risk Assessment; 5 Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements; 6 Stratification of Dyslipidemic Risk; 7 Drugs for Treatment of Blood Lipoprotein Abnormalities; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; V; W; X; Z

Notes:

Description based upon print version of record.

Includes bibliographical references and index.

Description based on metadata supplied by the publisher and other sources.

ISBN:

1-283-57735-6

9786613889805

0-19-978037-4

OCLC:

806039918